Abstract

The Philadelphia chromosome is present in more than 95% of chronic myeloid leukemia patients and 13% of acute lymphocytic leukemia patients. The Philadelphia translocation, t(9;22), fuses the BCR and ABL genes resulting in the expression of leukemia-specific, chimeric BCR-ABL messenger RNAs. To facilitate diagnosis of these leukemias, we have developed a method of amplifying and detecting only the unique mRNA sequences, using an extension of the polymerase chain reaction technique. Diagnosis of chronic myeloid and acute lymphocytic leukemias by this procedure is rapid, much more sensitive than existing protocols, and independent of the presence or absence of an identifiable Philadelphia chromosome.

Keywords

Myeloid leukemiaPhiladelphia chromosomebreakpoint cluster regionChronic lymphocytic leukemiaChromosomal translocationCancer researchABLLeukemiaMessenger RNAPolymerase chain reactionBiologyMyeloidGeneImmunologyMolecular biologyMedicineGeneticsTyrosine kinaseReceptor

Affiliated Institutions

Related Publications

Publication Info

Year
1988
Type
article
Volume
85
Issue
15
Pages
5698-5702
Citations
721
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

721
OpenAlex

Cite This

Ernest S. Kawasaki, SS Clark, Mazie Coyne et al. (1988). Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.. Proceedings of the National Academy of Sciences , 85 (15) , 5698-5702. https://doi.org/10.1073/pnas.85.15.5698

Identifiers

DOI
10.1073/pnas.85.15.5698